Usage And Safety
Dosage
Lacosamide IV infusion dosage & Administration.Loading Dose: Single Loading Dose 200mg IV Administer over 30-60 minsFollow up Dose: After 12 Hrs 200mg/day in 2 divided dosage for 5-7daysMaintenance Dose: 300-400mg per day in 2 divided dosage, Based on clinical response and tolerability.Injection should be administered intravenously & also can be mixed with any of the following diluents IV intravenously.Sodium Chloride Injection 0.9%, Dextrose Injection 5% & Lactated Ringer’s Injection. Always consult your doctor or pharmacist for dose adjustments.
Side Effects
The adverse events most commonly (>1% in the Lacosamide total group and greater than placebo) leading to discontinuation were dizziness, ataxia, vomiting, diplopia, nausea, vertigo, and vision blurred.
Drug Interactions
Medicines to treat heart problems , carbamazepine, lamotrigine or pregabalin, medicines used to treat certain types of irregular heart beat or heart failure, fluconazole, itraconazole or ketoconazole, ritonavir, clarithromycin or rifampicin, a herbal medicine used to treat mild anxiety and depression called St. John’s wort.
Indication
Lacosamide is indicated as a monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older.
When not to Use
Do not take Lacosamide:
• If you are allergic to lacosamide, or any of the other ingredients of this medicine. If you are not sure whether you are allergic, please discuss with your doctor.
• if you have a certain type of heart beat problem called second- or third-degree AV block.
Warnings
Warning 1
Treatment with lacosamide has been associated with dizziness which could increase the occurrence of accidental injury or falls.
Warning 2
Prolongations in PR interval with lacosamide have been observed in clinical studies. Lacosamide should be used with caution in patients with known conduction problems or severe cardiac disease such as a history of myocardial infarction or heart failure.
Warning 3
Lacosamide is not recommended for use in children & adolescents below the age of 16. The safety and effectiveness of Lacosamide in pediatric patients <17 years have not been established.